PALISADE BIO, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-15.7M | $-21.1M | $-20.9M | $-22.6M | $-19.8M | $-10.1M | $-12.5M | $-18.4M |
| Depreciation & Amortization | $289.2K | $337.5K | $345.5K | $348.6K | $244.7K | $211.1K | $187.1K | $130.8K |
| Depreciation | $100.0K | $161.0K | $148.0K | $137.0K | $126.0K | $101.0K | $104.0K | — |
| Amortization | $189.0K | $176.0K | $197.0K | $211.0K | $119.0K | $110.0K | $83.0K | — |
| Stock-Based Compensation | $1.8M | $3.4M | $3.0M | $4.3M | $2.3M | $1.6M | $3.3M | $5.2M |
| Net Cash from Operating Activities | $-13.4M | $-15.6M | $-18.9M | $-11.7M | $-10.6M | $-8.5M | $-8.1M | $-10.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $11.4K | $98.1K | $176.3K | $207.9K | $125.4K | $39.2K | $196.4K | $76.3K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-94.0K | $2.4M | — | — | — | $-254.9K | $-480.9K | $-332.7K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $5.0M | $23.7M | — | — | — | $13.8M | $1.7M | $17.3M |
| Net Change in Cash | $-8.5M | $10.5M | $-7.8M | $-4.3M | $9.4M | $5.1M | $-6.9M | $7.0M |
| Free Cash Flow | $-13.4M | $-15.7M | $-19.1M | $-11.9M | $-10.7M | $-8.5M | $-8.3M | $-10.1M |